查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566894

退伍军人菌检测套组市场：按类型、最终用户划分：2024-2033 年全球机会分析与产业预测

Legionella Testing Kits Market By Type , By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 260 Pages | 商品交期: 2-3个工作天内

价格
简介目录

退伍军人菌检测套组市场

2023 年退伍军人菌检测套组市值为 3.24 亿美元，预计 2024 年至 2033 年复合年增长率为 7.7%，到 2033 年将达到 6.845 亿美元。

退伍军人菌检测套组是快速 DIY 测试仪，可检测退伍军人菌。该套件主要用于疗养院、医院、餐旅服务业、游泳池、喷泉和冷却塔等空间。使用各种生物分子过程进行测试，包括培养、聚合酵素链锁反应和免疫测定。套件的主要特点包括交付快、精度高、易于使用。

对预防水传播感染疾病的认识不断提高是退伍军人菌检测套组市场的主要驱动因素。日益严格的公共法规正在推动商业和公共设施中采用检测套组。此外，技术进步正在提高检测套组的有效性和可靠性，支持市场开拓。最近的趋势包括快速交付测试结果以及与数位解决方案的整合。为了促进测试结果的无缝分析和报告，製造商正在设计可以与数位资料管理系统整合的套件。这种整合可帮助您追踪水质和安全模式并做出有效的决策。

然而，高精度和高精度的高级版本套件的成本仍然相当高，限制了小型组织的购买。此外，样本采集和套件处理是复杂的过程，需要培训和实践。套件的轻微污染会影响其可靠性并阻碍市场成长。相反，政府在公共场所和建筑物中定期进行水质检测的倡议正在为市场创造利润丰厚的机会。例如，在美国，将于 2024 年 1 月对多栋联邦政府大楼进行水质检测，以确保在大楼内参观或工作的人员的健康。

按部门审查

退伍军人菌检测套组市场按类型、最终用户和地区细分。按类型划分，市场分为培养基、尿液抗原测试、聚合酵素链锁反应、血清学和直接萤光抗体测试。依最终使用者分为医院/诊所、临床实验室等。从区域来看，我们对北美、欧洲、亚太地区和拉丁美洲地区进行了分析。

主要发现

按类型划分，聚合酵素链锁反应领域在 2023 年占据最大份额。

从最终用户来看，医院和诊所细分市场将在 2023 年获得较高的市场份额。

按地区划分，北美地区 2023 年收益最高。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 根据客户兴趣加入公司简介

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 主要投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章退伍军人菌检测套组市场：按类型

  • 市场概况
  • 培养基
  • 尿液抗原检测
  • 聚合酵素链锁反应
  • 血清检测
  • 直接萤光抗体测试

第五章退伍军人菌检测套组市场：依最终用户分类

  • 市场概况
  • 医院和诊所
  • 临床实验室
  • 其他的

第六章退伍军人菌检测套组市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国退伍军人菌检测套组市场
    • 加拿大军团退伍军人菌检测套组市场
    • 墨西哥军团退伍军人菌检测套组市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国退伍军人菌检测套组市场
    • 德国军团退伍军人菌检测套组市场
    • 义大利退伍军人菌检测套组市场
    • 西班牙退伍军人菌检测套组市场
    • 英国退伍军人菌检测套组市场
    • 其他欧洲国家退伍军人菌检测套组市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国退伍军人菌检测套组市场
    • 日本退伍军人菌检测套组市场
    • 印度退伍军人菌检测套组市场
    • 韩国退伍军人菌检测套组市场
    • 澳洲军团退伍军人菌检测套组市场
    • 其他亚太军团退伍军人菌检测套组市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西军团退伍军人菌检测套组市场
    • 南非军团退伍军人菌检测套组市场
    • 沙乌地阿拉伯军团退伍军人菌检测套组市场
    • 其他拉丁美洲/中东/非洲军团退伍军人菌检测套组市场

第七章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第八章 公司简介

  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific
  • Merck Group KGaA
  • Pall Corporation
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Hygiena
  • Veolia Water Technologies
  • Pro-Lab Diagnostics
  • Phigenics, LLC
简介目录
Product Code: A264537

Legionella Testing Kits Market

The legionella testing kits market was valued at $324.0 million in 2023 and is projected to reach $684.5 million by 2033, growing at a CAGR of 7.7% from 2024 to 2033.

A legionella testing kit is a rapid do-it-yourself tester which enables detection of the bacteria Legionella. This kit is essentially used in spaces such as care homes & hospitals, hospitality, pools & fountains, and cooling towers. The testing is performed using diverse biomolecular processes such as culture method, polymerase chain reaction technique, or immunological assay. The key attributes of the kit include short turnaround time, high precision, and ease of usage.

Increase in awareness about the prevention of water borne diseases is a key driver of the legionella testing kits market. Commercial and public buildings have strengthened their regulations regarding public safety, boosting the adoption of testing kits. In addition, advancements in technology have enhanced the efficacy and reliability of the kits, thereby augmenting the development of the market. In recent times, quick delivery of results and integration of the kits with digital solutions are the prominent trends acquiring traction. To facilitate seamless analysis and reporting of test results, manufacturers are designing kits with the ability to be assimilated with digital data management systems. This integration assists in tracking the patterns of water quality & safety and making effective decisions.

However, the cost of advanced version of kits with high precision and accuracy remains significantly high, restricting small organizations from purchasing them. Furthermore, the collection and handling of the sample & kit is a complex process which requires training & practice. Slight contamination of the kit impacts its reliability, thereby hampering the growth of the market. Contrarily, efforts by governments to conduct periodic water testing in public places and buildings are presenting lucrative opportunities for the market. For instance, the U.S. General Service Administration conducted water testing across several federal buildings in January 2024 to ensure the wellness of individuals visiting and working in the buildings.

Segment Review

The legionella testing kits market is segmented into type, end user, and region. On the basis of type, the market is divided into culture media, urine antigen testing, polymerase chain reaction, serology, and direct fluorescent antibody test. Depending on end user, it is classified into hospitals & clinics, clinical laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of type, the polymerase chain reaction segment accounted for the largest share in 2023.

Depending on end user, the hospitals & clinics segment acquired a high stake in the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global legionella testing kits market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Merck Group KGaA, Pall Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Hygiena, Veolia Water Technologies, Pro-Lab Diagnostics, and phigenics, llc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest

Key Market Segments

By Type

  • Culture Media
  • Urine Antigen Testing
  • Polymerase Chain Reaction
  • Serology
  • Direct Fluorescent Antibody Test

By End User

  • Hospitals and Clinics
  • Clinical Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • IDEXX Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Merck Group KGaA
    • Pall Corporation
    • Bio-Rad Laboratories, Inc.
    • Abbott Laboratories
    • Hygiena
    • Veolia Water Technologies
    • Pro-Lab Diagnostics
    • Phigenics, LLC

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: LEGIONELLA TESTING KITS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Culture Media
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Urine Antigen Testing
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Polymerase Chain Reaction
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country
  • 4.5. Serology
    • 4.5.1. Key Market Trends, Growth Factors and Opportunities
    • 4.5.2. Market Size and Forecast, By Region
    • 4.5.3. Market Share Analysis, By Country
  • 4.6. Direct Fluorescent Antibody Test
    • 4.6.1. Key Market Trends, Growth Factors and Opportunities
    • 4.6.2. Market Size and Forecast, By Region
    • 4.6.3. Market Share Analysis, By Country

CHAPTER 5: LEGIONELLA TESTING KITS MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals And Clinics
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Clinical Laboratories
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Others
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: LEGIONELLA TESTING KITS MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Type
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Legionella Testing Kits Market
      • 6.2.5.1. Market Size and Forecast, By Type
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Legionella Testing Kits Market
      • 6.2.6.1. Market Size and Forecast, By Type
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Legionella Testing Kits Market
      • 6.2.7.1. Market Size and Forecast, By Type
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Type
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. France Legionella Testing Kits Market
      • 6.3.5.1. Market Size and Forecast, By Type
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. Germany Legionella Testing Kits Market
      • 6.3.6.1. Market Size and Forecast, By Type
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. Italy Legionella Testing Kits Market
      • 6.3.7.1. Market Size and Forecast, By Type
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Spain Legionella Testing Kits Market
      • 6.3.8.1. Market Size and Forecast, By Type
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. UK Legionella Testing Kits Market
      • 6.3.9.1. Market Size and Forecast, By Type
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Legionella Testing Kits Market
      • 6.3.10.1. Market Size and Forecast, By Type
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Type
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. China Legionella Testing Kits Market
      • 6.4.5.1. Market Size and Forecast, By Type
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. Japan Legionella Testing Kits Market
      • 6.4.6.1. Market Size and Forecast, By Type
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. India Legionella Testing Kits Market
      • 6.4.7.1. Market Size and Forecast, By Type
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. South Korea Legionella Testing Kits Market
      • 6.4.8.1. Market Size and Forecast, By Type
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. Australia Legionella Testing Kits Market
      • 6.4.9.1. Market Size and Forecast, By Type
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Legionella Testing Kits Market
      • 6.4.10.1. Market Size and Forecast, By Type
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Type
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Legionella Testing Kits Market
      • 6.5.5.1. Market Size and Forecast, By Type
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. South Africa Legionella Testing Kits Market
      • 6.5.6.1. Market Size and Forecast, By Type
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. Saudi Arabia Legionella Testing Kits Market
      • 6.5.7.1. Market Size and Forecast, By Type
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Legionella Testing Kits Market
      • 6.5.8.1. Market Size and Forecast, By Type
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. IDEXX Laboratories, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Thermo Fisher Scientific
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Merck Group KGaA
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Pall Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Bio-Rad Laboratories, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Abbott Laboratories
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Hygiena
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Veolia Water Technologies
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Pro-Lab Diagnostics
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Phigenics, LLC
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments